MX338611B - Una composicion farmaceutica sinergistica novedosa para aplicaciones topicas. - Google Patents

Una composicion farmaceutica sinergistica novedosa para aplicaciones topicas.

Info

Publication number
MX338611B
MX338611B MX2012014051A MX2012014051A MX338611B MX 338611 B MX338611 B MX 338611B MX 2012014051 A MX2012014051 A MX 2012014051A MX 2012014051 A MX2012014051 A MX 2012014051A MX 338611 B MX338611 B MX 338611B
Authority
MX
Mexico
Prior art keywords
novel
synergistic
composition
topical formulations
silver
Prior art date
Application number
MX2012014051A
Other languages
English (en)
Spanish (es)
Other versions
MX2012014051A (es
Inventor
Krishna Mohan Vadrevu
Venkata Cherish Badu Pelluri
Khajesh Sharma
Original Assignee
Bharat Biotech Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Biotech Int Ltd filed Critical Bharat Biotech Int Ltd
Publication of MX2012014051A publication Critical patent/MX2012014051A/es
Publication of MX338611B publication Critical patent/MX338611B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/345—Nitrofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2012014051A 2010-06-03 2010-07-14 Una composicion farmaceutica sinergistica novedosa para aplicaciones topicas. MX338611B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1534CH2010 2010-06-03
PCT/IN2010/000468 WO2011151835A1 (fr) 2010-06-03 2010-07-14 Nouvelle composition pharmaceutique synergique pour applications topiques

Publications (2)

Publication Number Publication Date
MX2012014051A MX2012014051A (es) 2013-02-15
MX338611B true MX338611B (es) 2016-04-25

Family

ID=43466804

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012014051A MX338611B (es) 2010-06-03 2010-07-14 Una composicion farmaceutica sinergistica novedosa para aplicaciones topicas.

Country Status (12)

Country Link
US (1) US9427459B2 (fr)
EP (1) EP2575861B1 (fr)
JP (1) JP5824513B2 (fr)
KR (1) KR101457509B1 (fr)
CN (1) CN102939097B (fr)
AU (1) AU2010354681C1 (fr)
BR (1) BR112012030261B1 (fr)
CA (1) CA2800417C (fr)
CO (1) CO6650416A2 (fr)
MX (1) MX338611B (fr)
RU (1) RU2571506C2 (fr)
WO (1) WO2011151835A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932624B2 (en) 2007-06-20 2015-01-13 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
US9981069B2 (en) 2007-06-20 2018-05-29 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
US9511040B2 (en) 2007-06-20 2016-12-06 The Trustees Of Columbia University In The City Of New York Skin and surface disinfectant compositions containing botanicals
US9687429B2 (en) 2007-06-20 2017-06-27 The Trustees Of Columbia University In The City Of New York Antimicrobial compositions containing low concentrations of botanicals
US9968101B2 (en) 2011-11-03 2018-05-15 The Trustees Of Columbia University In The City Of New York Botanical antimicrobial compositions
ES2762405T3 (es) 2011-11-03 2020-05-25 Univ Columbia Composición con actividad antimicrobiana sostenida
WO2013086094A1 (fr) 2011-12-06 2013-06-13 The Trustees Of Columbia University In The City Of New York Composition d'agent de conservation naturelle à large spectre
CN103182070B (zh) * 2013-04-12 2014-02-12 江苏迪沃生物制品有限公司 一种外用组合物、制剂及其应用
CN103784463B (zh) * 2014-01-28 2015-04-22 滨州医学院附属医院 一种新复方磺胺嘧啶银混悬剂及其制备方法
JP6987039B2 (ja) 2015-08-24 2021-12-22 スミス アンド ネフュー インコーポレイテッド 抗菌剤と組み合わせた中極性油の細菌性バイオフィルムに対する相乗的抗菌活性
US10420815B2 (en) * 2015-09-15 2019-09-24 The Governors Of The University Of Alberta Combinational therapy for synergistic inhibition of gram-positive and gram-negative bacteria
CN105251011B (zh) * 2015-11-13 2018-12-28 广州骏思知识产权管理咨询有限公司韶关分公司 一种用于浅度烧伤的喷膜剂及其制备方法
CN105214093B (zh) * 2015-11-16 2016-10-26 马文学 一种复方微胶愈伤护理液
WO2018143911A1 (fr) 2017-01-31 2018-08-09 Kimberly-Clark Worldwide, Inc. Composition antibactérienne comprenant un ester d'acide benzoïque et procédés d'inhibition de la croissance bactérienne utilisant celle-ci
CN107625725B (zh) * 2017-09-08 2021-11-16 中国科学院过程工程研究所 基于氨基酸的含纳米银的抗菌水凝胶及其制备方法和用途
CN111518288B (zh) * 2020-05-13 2022-06-24 福州大学 一种复合水凝胶伤口敷料及其制备方法
CN113813283B (zh) * 2020-06-19 2023-12-12 中山大学附属第六医院 一类化合物促皮肤损伤修复的用途
CN113599506B (zh) * 2021-05-31 2023-07-21 长沙理工大学 一种铂纳米酶/葡萄糖氧化酶@透明质酸复合抗菌材料及其制备和应用
KR20240120380A (ko) * 2023-01-31 2024-08-07 아주대학교산학협력단 신규한 히스톤탈아세틸화 효소 억제용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7563461B2 (en) * 2002-02-07 2009-07-21 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
AU2003303783A1 (en) * 2003-01-16 2004-08-13 Xylos Corporation Microbial-derived cellulose amorphous hydrogel wound dressing
BRPI0610704B8 (pt) * 2005-05-27 2021-05-25 Bharat Biotech Int Ltd composição do fator de crescimento epidérmico, o processo para isso e sua aplicação

Also Published As

Publication number Publication date
KR20130043145A (ko) 2013-04-29
KR101457509B1 (ko) 2014-11-05
US20130085103A1 (en) 2013-04-04
AU2010354681C1 (en) 2015-02-05
US9427459B2 (en) 2016-08-30
CO6650416A2 (es) 2013-04-15
CA2800417A1 (fr) 2011-12-08
WO2011151835A1 (fr) 2011-12-08
CN102939097B (zh) 2016-05-11
CN102939097A (zh) 2013-02-20
CA2800417C (fr) 2018-08-28
BR112012030261B1 (pt) 2019-12-03
AU2010354681B2 (en) 2014-08-28
JP2013527229A (ja) 2013-06-27
EP2575861B1 (fr) 2015-11-04
BR112012030261A2 (pt) 2017-10-31
RU2012156266A (ru) 2014-07-20
EP2575861A1 (fr) 2013-04-10
JP5824513B2 (ja) 2015-11-25
MX2012014051A (es) 2013-02-15
AU2010354681A1 (en) 2012-12-20
RU2571506C2 (ru) 2015-12-20

Similar Documents

Publication Publication Date Title
MX338611B (es) Una composicion farmaceutica sinergistica novedosa para aplicaciones topicas.
ES2925876T3 (es) Nuevo tratamiento de las úlceras crónicas
Khorasani et al. Aloe versus silver sulfadiazine creams for second-degree burns: a randomized controlled study
Yan et al. Recombinant human granulocyte-macrophage colony-stimulating factor hydrogel promotes healing of deep partial thickness burn wounds
Patel et al. Manuka honey: an emerging natural food with medicinal use
ES2864373T3 (es) Métodos para la cicatrización
US11096992B2 (en) Use of seaprose to remove bacterial biofilm
Leon-Villapalos et al. Topical management of facial burns
BR112013026032A2 (pt) composições nutricionais incluindo ácidos graxos de cadeia ramificada para cicatrização de ferida
WO2012017349A3 (fr) Composition pharmaceutique topique améliorée comprenant de la sulfadiazine d'argent de taille nanométrique
AR112474A1 (es) Composición tópica semisólida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños crónicos de la piel
CU24390B1 (es) Piperidinil-tetrahidroquinolinas sustituidas
CN105107007A (zh) 一种阳离子医用护创敷料及其制备方法
Radzikowska-Büchner et al. An overview of recent developments in the management of burn injuries
CR20160277A (es) Piperidinil tetrahidroquinolinas sustituidas
RU2015142443A (ru) Синергетическая комбинация аланин-глутамина, гиалуроновой кислоты и экстракта овса и ее применение в композиции для заживления ран и восстановления повреждений кожи
CN111012944A (zh) 一种基于藻酸盐和透明质酸的液体敷料及其制备方法
RU2012135969A (ru) Способ лечения длительно незаживающей раны и/или раневой полости
EA202092077A1 (ru) Местные составы, содержащие стронций и метилсульфонилметан (мсм), и способы лечения
Karri et al. Understanding the implications of pharmaceutical excipients and additives in the treatment of diabetic foot ulcers
CN103271938A (zh) 一种治疗烧伤、烫伤及炸伤的药物组方
SE0401943D0 (sv) New use
EP2663335A1 (fr) Composition pour régénérer des tissus atrophiques
Bhatia et al. Optimizing wound healing for cosmetic and medical dermatologic procedures
TH127480A (th) องค์ประกอบในทางเภสัชกรรมมีฤทธิ์เสริมร่วมชนิดใหม่สำหรับการใช้งานเฉพาะแห่ง

Legal Events

Date Code Title Description
FG Grant or registration